Synthesis of 1‐(alkoxymethyl)‐5‐benzyl‐6‐methyluracil As Potential Nonnucleoside HIV‐1 RT Inhibitors.

Yanli Chen,Ying Guo,Hua Yang,Xiaowei Wang,Junyi Liu

DOI: https://doi.org/10.1002/chin.200711132

2007-01-01

ChemInform

Abstract:AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

What problem does this paper attempt to address?

Synthesis of l‐(Alkoxymethyl)‐5‐benzyl‐6‐methyluracil as Potential Nonnucleoside HIV‐1 RT Inhibitors

Yanli Chen,Ying Guo,Hua Yang,Xiaowei Wang,Junyi Liu

DOI: https://doi.org/10.1080/00397910600772850

2007-01-01

Synthetic Communications

Abstract:1,3-Dibenzyl-6-methyl-5-zincbromomethyluracil 6 was prepared starting from 6-methyluracil 1. The cross-coupling reaction of benzylic zinc reagent 6 with PhI using bis(dibenzylideneacetone) palladium( 0) and (o-furyl)(3)P as catalyst gave 1,3,5-tribenzyl-6-methyluracil 7. The N-1, N-3-dibenzyl group could be removed in dealkylation to give the 5-benzyl-6-methyluracil 8. It was N-1-alkylated with chloromethyl ethyl ether or chloromethyl benzyl ether to obtained the targets 9a and b. All synthesized compounds were tested for their inhibition of HIV-1 reverse transcriptase, and moderate activity were found for target compounds 9a and b and 5.
Nonnucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 1. Synthesis and Structure—Activity Relationship of 1‐alkoxymethyl‐5‐alkyl‐6‐naphthylmethyl Uracils As HEPT Analogues.

Ge Meng,Fen‐Er Chen,Erik De Clercq,Jan Balzarini,Christophe Pannecouque

DOI: https://doi.org/10.1002/chin.200350163

2003-01-01

ChemInform

Abstract:AbstractFor Abstract see ChemInform Abstract in Full Text.
A convenient synthesis of 1-alky1-5-amino-6-phenylethyluracils as potential non-nucleoside HIV-1RT inhibitors

Xiao-Yan Ma,Zhi-Jian Cheng,Yan-Li Chen,A-Min Li,Zhi-Li Zhang,Xiao-Wei Wang,Jun-Yi Liu

2008-01-01

Abstract:1-Alkyl-5-amino-6-phenylethyluraeils (1a,1b) were synthesized as potential non-nueleoside HIV-1 RT inhibitors.A convenient synthetic procedure was developed for the preparation of l-alkyl-5-amino or 5-aminosubstituted-6-phenylethyluraeils,which were synthesized in three or four steps from 6-methyluracil in good yield.The development of a one-pot reaction that simulta- neously removed the benzyl protection group and reduced the nitro group greatly improved the yield of the synthesis.Compounds 1a and 1b are analogs of MKC-442,which is an efficient inhibitor of HIV-1 reverse transcriptase,1a and 1b were tested for their inhibition of HIV- 1RT,and moderate activity was found for 1a.
Synthesis of 1-(Alkyl)-5-dimethylamino-6-phenethyluracils as Potent Nonnucleoside HIV-1 RT Inhibitors

Xiaowei Wang,Yanli Chen,Ying Guo,Amin Li,Xiaoyan Ma,Junyi Liu

DOI: https://doi.org/10.1080/00397910701412737

2007-01-01

Synthetic Communications

Abstract:1-(Alkyl)-5-dimethylamino-6-phenethyl uracils (1) and (2) are analogs of MKC-442, which is a very potent inhibitor of HIV-1 reverse transcriptase. The target compound 1 was synthesized by the first approach, from the corresponding 1,3-dibenzyl-5-(dimethylamino)-6-phenethylpyrimidine-2,4(1H,3H)-dione (7), which was synthesized in four steps from 6-methyluracil (3) by nitration, benzylation, reduction, and methylation of the amino group. Compound 7 was then debenzylated to give the complete deprotected compound 8 with very low yield. To improve the yield, another pathway was developed for introducing the ethoxymethyl group at N-1 of the uracil ring first. The result of adjusting reaction sequences increased the overall yield dramatically. All synthesized compounds were tested for their inhibition of HIV-1 reverse transcriptase, and moderate activity was found for target compound 1.
The Design and Synthesis of N-1-Alkylated-5-Aminoaryalkylsubstituted-6-Methyluracils As Potential Non-Nucleoside Hiv-1 Rt Inhibitors

Xiao Lu,Yanli Chen,Ying Guo,Zhenming Liu,Yawei Shi,Yang Xu,Xiaowei Wang,Zhili Zhang,Junyi Liu

DOI: https://doi.org/10.1016/j.bmc.2007.07.058

IF: 3.461

2007-01-01

Bioorganic & Medicinal Chemistry

Abstract:Novel compounds 1a-u, which can be considered as hybrid analogues of MKC-442 and pyridinon, have been synthesized and evaluated as inhibitors of HIV-1 reverse transcriptase (HIV-1 RT). Starting from 6-methyluracil 2, 1-alkylated-5-bromomethyl-6-methyluracils 8 was prepared in four steps by hydroxymethylation, etherification, N-1 alkylation, and bromination. Finally, compounds 1a-u were achieved in the displacement of 5-bromomethyl group by nucleophiles with amino compounds. Some of compounds 1a-u showed potent inhibitory activity against HIV-1 RT. The most active compounds showed activity in the low micromolecular range with IC(50) values (IC(50) 0.82-5.09 microM) comparable to that of nevirapine (IC(50) 10.60 microM). The biological testing results are in accordance with the docking.
ChemInform Abstract: Structure‐Based Design, Synthesis and Biological Evaluation of New N‐Carboxyphenylpyrrole Derivatives as HIV Fusion Inhibitors Targeting gp41.

Yong Wang,Hong Lu,Qiang Zhu,Shibo Jiang,Yun Liao

DOI: https://doi.org/10.1002/chin.201021109

2010-01-01

ChemInform

Abstract:AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 7. Synthesis, Antiviral Activity, and 3D‐QSAR Investigations of Novel 6‐(1‐naphthoyl) HEPT Analogues.

Lei Ji,Fen‐Er Chen,Xiao‐Qing Feng,Erik De Clercq,Jan Balzarini,Christophe Pannecouque

DOI: https://doi.org/10.1002/chin.200708160

2007-01-01

ChemInform

Abstract:AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Synthesis and Biological Evaluation of Novel 1-Aryl-5-iodo-6-benzyluracils As Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors

Wei Wang,Li,Chang Liu,Liang Zhang,Han Yan,Zhi-Li Zhang,Xiao-Wei Wang,Jun-Yi Liu

DOI: https://doi.org/10.5246/jcps.2010.04.044

2010-01-01

Abstract:We have synthesized the novel compounds la-li,which are a series of hybrid analogues to 6-benzyl-1-(benzyloxymethyl)-5-iodouracil,a compound showing strong activity against HIV-1.We also evaluated the activity of these compounds as the inhibitors of HIV-1 reverse transcriptase(HIV-1 RT),and they have demonstrated moderate activity.
ChemInform Abstract: Improved Synthesis of 1‐[hexahydrocyclopenta [C]pyrrol‐2(1h)‐yl]‐3‐(4‐methylbenzenesulfonyl)urea.

Chao Qian,Yan Liu,Xinzhi Chen

DOI: https://doi.org/10.1002/chin.200915117

2009-01-01

ChemInform

Abstract:AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Design, Synthesis and Biological Evaluations of Novel Oxindoles As HIV‐1 Non‐Nucleoside Reverse Transcriptase Inhibitors. Part 1.

Tao Jiang,Kelli Kuhen,Karen Wolff,Hong Yin,Kimberly Bieza,Jeremy S. Caldwell,Badry Bursulaya,Tom Yao‐Hsing Wu,Yan He

DOI: https://doi.org/10.1002/chin.200629096

2006-01-01

ChemInform

Abstract:ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Study On Hiv-1 Rt Inhibitor - I. Synthesis Of 1,3-Dibenzyl-6-(3,4-Epoxybutyl)Uracil

Xw Wang,Zl Zhang,J Liu,Xy Ma,Jy Liu

2004-01-01

Chinese Journal of Organic Chemistry

Abstract:An efficient practical synthetic method for preparing 1,3-dibenzyl-6- (3,4-epoxybutyl) uracil (5) has been realized from 6-methyluracil (1). The title compound 5 is a key intermediate compound of HIV-1RT and methionine synthase inhibitors. 6-Methyluracil (1) was used as starting material to react with benzyl bromide giving 1,3-dibenzyl-6-methyluracil (2), which reacted with allyl bromide to afford 1,3-dibenzyl-6-(3-butenyl)uracil (3). Compound 3 reacted with NBS in DMSO-H2O to yield 4, which was converted into the title compound 5 under basic conditions in good yield.
Synthesis and biological evaluation of novel 2-arylalkylthio-4-amino-6-benzyl pyrimidines as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.

Hua Qin,Chang Liu,Jianfang Zhang,Ying Guo,Siwei Zhang,Zhili Zhang,Xiaowei Wang,Liangren Zhang,Junyi Liu

DOI: https://doi.org/10.1016/j.bmcl.2009.04.051

IF: 2.94

2010-01-01

Bioorganic & Medicinal Chemistry Letters

Abstract:A number of novel 2-arylalkylthio-4-amino-6-benzyl pyrimidines were designed and synthesized as potent NNRTIs. The results showed that the changes of N3H–C4O into N3C4–NH2 could increase the activity.
ChemInform Abstract: Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 11. Structural Modulations of Diaryltriazines with Potent Anti‐hiv Activity.

Yuan‐Zhen Xiong,Fen‐Er Chen,Jan Balzarini,Erik De Clercq,Christophe Pannecouque

DOI: https://doi.org/10.1002/chin.200840167

2008-01-01

ChemInform

Abstract:ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Design, Synthesis, and Biological Evaluation of 1-[(2-benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils As Potent Hiv-1 Non-Nucleoside Reverse Transcriptase Inhibitors with an Improved Drug Resistance Profile

Xiaowei Wang,Jianfang Zhang,Yang Huang,Ruiping Wang,Liang Zhang,Kang Qiao,Li,Chang Liu,Yabo Ouyang,Weisi Xu,Zhili Zhang,Liangren Zhang,Yiming Shao,Shibo Jiang,Liying Ma,Junyi Liu

DOI: https://doi.org/10.1021/jm201506e

IF: 8.039

2012-01-01

Journal of Medicinal Chemistry

Abstract:Because the emergence of drug-resistant mutants has limited the efficacy of non-nucleoside reverse transcriptase inhibitors (NNRTIs), it is essential to develop new antivirals with better drug resistance and pharmacokinetic profiles. Here we designed and synthesized a series of 1-[(2-benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils, the HEPT analogues, and evaluated their biological activity using nevirapine and 18 (TNK-651) as reference compounds. Most of these compounds, especially 6b, 7b, 9b, 11b, and 7c, exhibited highly potent anti-HIV-1 activity against both wild-type and NNRTI-resistant HIV-1 strains. Compound 7b, which had the highest selectivity index (SI = 38 215), is more potent than nevirapine and 18. These results suggest that the introduction of a halogen at the C-5 position may contribute to the effectiveness of these compounds against RTI-resistant variants. In addition, meta substituents on the C-6 aromatic moiety could significantly enhance activity against NNRTI-resistant HIV-1 strains. These compounds can be further developed as next-generation NNRTIs with an improved antiviral efficacy and drug-resistance profile.
Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors: Part I. Synthesis and Structure-Activity Relationship of 1-Alkoxymethyl-5-alkyl-6-naphthylmethyl Uracils As HEPT Analogues.

G Meng,FE Chen,E De Clercq,J Balzarini,C Pannecouque

DOI: https://doi.org/10.1248/cpb.51.779

2003-01-01

Chemical and Pharmaceutical Bulletin

Abstract:1-alkoxymethyl-5-alkyl-6-naphthylmethyl uracils, which are novel 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) analogues, were synthesized for evaluation as selective and potent nonnucleoside human immunodeficiency virus (HIV)-1 reverse transcriptase inhibitors. The anti-HIV-1 activity of these compounds was assayed in vitro using HIV-1 infected MT-4 and CEM bioassays. The EC50, CC50 and SI were recorded and calculated. The appropriate position, especially in the 1-position of the naphthyl ring, led to dramatic increases in potency, in both MT-4 and CEM cellular assays. The most important compounds in this series, 1-ethoxymethyl-5-isopropyl-6-(1-naphthylmethyl)thymine 8l (IC50=17 nM, CC50=38332 nM, SI=2229) and 1-benzyloxymethyl-5-ethyl-6-(1-naphthylmethyl)thymine 8n (IC50=17 nM, CC50=32560 nM, SI=1889) were significantly more potent than HEPT (EC50=7.0 microM, CD50=740 microM) in the anti-HIV-1 in vitro cellular assay.
Design, synthesis and anti-HIV evaluation of 5-alkyl- 6-(benzo[d][1,3]dioxol-5-alkyl)-2-mercaptopyrimidin-4(3H)-ones as potent HIV-1 NNRTIs

Yi-Ming Li,Rong-Hua Luo,Liu-Meng Yang,Si-Ming Huang,Sui-Yuan Li,Yu-Gui Zheng,Dong-Xuan Ni,Yi-Man Cui,Xing-Jie Zhang,Xiao-Li Li,Rui-Han Zhang,E Tang,Hong-Bin Zhang,Yong-Tang Zheng,Yan-Ping He,Wei-Lie Xiao

DOI: https://doi.org/10.1016/j.bioorg.2020.104041

IF: 5.307

2020-09-01

Bioorganic Chemistry

Abstract:In order to discover and develop the new HIV-1 Centrist, a series of 5-alkyl-6-(benzo[d][1,3]dioxol-5-ylalkyl)-2-mercaptopyrimidin-4(3H)-ones was synthesized and screened for their in vitro cytotoxicity against HIV-1. Most of the compounds we synthetized showed high activity against wild-type HIV-1 strain (IIIB) while IC50 values are in the range of 0.06-12.95μM. Among them, the most active HIV-1 inhibitor was compound 6-(benzo[d][1,3]dioxol-5-ylmethyl)-5-ethyl-2-((2-(4-hydroxyphenyl)-2-oxoethyl)thio)pyrimidin-4(3H)-one (5b), which exhibited similar HIV-1 inhibitory potency (IC50 = 0.06μM, CC50 = 96.23μM) compared with nevirapine (IC50 = 0.04μM, CC50 >200μM) and most of compounds exhibited submicromolar IC50 values indicating they were specific RT inhibitors. The compounds 5b, 6-(benzo[d] [1,3]dioxol-5-yl)-5-ethyl-2-((2-(4-hydroxyphenyl)-2-oxoethyl)thio)pyrimidin-4(3H)-one (5c) and 4-(2-((4-(benzo[d][1,3]dioxol-5-ylmethyl)-5-ethyl-6-oxo-1,6-dihydro pyrimidin-2-yl)thio)acetyl)phenylbenzo[d][1,3]dioxole-5-carboxylate (5r) were selected for further study. It was found that all of them had little toxicity to peripheral blood mononuclear cell (PBMC), and had a good inhibitory effect on the replication of HIV-1 protease inhibitor resistant strains, fusion inhibitor resistant strains and nucleosides reverse transcriptase inhibitor resistant strains, as well as on clinical isolates. Besides, compound 5b and 5c showed inhibition of HIV-1 RT RNA-dependent DNA polymerization activity and DNA-dependent DNA polymerization activity, while compound 5r only showed inhibition of HIV DNA-dependent DNA polymerization activity, which was different from classical reverse transcriptase inhibitors. Our study which offered the preliminary structure-activity relationships and modeling studies of these new compounds has provided the valuable avenues for future molecular optimization.

biochemistry & molecular biology,chemistry, organic
ChemInform Abstract: Synthesis and HIV‐1 Integrase Inhibition Activity of Some N‐Arylindoles.

Hui Xu,Wu‐Qing Liu,Lingling Fan,Yang Chen,Liu‐Meng Yang,Lei Lv,Yong‐Tang Zheng

DOI: https://doi.org/10.1002/chin.200842102

2008-01-01

ChemInform

Abstract:ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
ChemInform Abstract: N‐[2‐(1‐Cyclohexenyl)ethyl]‐N′‐[2‐(5‐bromopyridyl)]‐thiourea and N′‐[2‐(1‐Cyclohexenyl)ethyl]‐N′‐[2‐(5‐chloropyridyl)]‐thiourea As Potent Inhibitors of Multidrug‐Resistant Human Immunodeficiency Virus‐1.

Fatih M. Uckun,Mao Chen,Sharon Pendergrass,Danielle Maher,Dan Zhu,Lisa Tuel‐Ahlgren,T.K. Venkatachalam

DOI: https://doi.org/10.1002/chin.199952147

1999-01-01

ChemInform

Abstract:ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Synthesis and Antifungal Activity of 2-Aryl-1,2,4-triazolo[1,5-a]pyridine Derivatives.

Yun Luo,Yongzhou Hu

DOI: https://doi.org/10.1002/chin.200635153

2006-01-01

ChemInform

Abstract:ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Synthesis and Biological Evaluation of (±)-Benzhydrol Derivatives As Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.

Xiao-Dong Ma,Xuan Zhang,Shi-Qiong Yang,Hui-Fang Dai,Liu-Meng Yang,Shuang-Xi Gu,Yong-Tang Zheng,Qiu-Qin He,Fen-Er Chen

DOI: https://doi.org/10.1016/j.bmc.2011.07.003

IF: 3.461

2011-01-01

Bioorganic & Medicinal Chemistry

Abstract:A series of (±)-benzhydrol derivatives featuring the essential sulfonamide group at the para position on the C-ring were synthesized and evaluated for the potential anti-HIV activity in C8166 cells. Most of these analogues demonstrated low concentration inhibitory activity with EC(50) values less than 1 μM against the wild-type HIV-1. In particular, compound 7h was identified as the highest active inhibitor of wild-type HIV-1 with an EC(50) value of 0.12 μM and selectivity index value of 312.73. Furthermore, some of them also exhibited moderate activity against the double mutant strain A(17) (K103N+Y181C) with EC(50) values lower than 5 μM. In addition, the binding modes with RT and the preliminary structure-activity relationships of these derivatives were also explored for further chemical modifications.

Synthesis of 1‐(alkoxymethyl)‐5‐benzyl‐6‐methyluracil As Potential Nonnucleoside HIV‐1 RT Inhibitors.

Synthesis of l‐(Alkoxymethyl)‐5‐benzyl‐6‐methyluracil as Potential Nonnucleoside HIV‐1 RT Inhibitors

Nonnucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 1. Synthesis and Structure—Activity Relationship of 1‐alkoxymethyl‐5‐alkyl‐6‐naphthylmethyl Uracils As HEPT Analogues.

A convenient synthesis of 1-alky1-5-amino-6-phenylethyluracils as potential non-nucleoside HIV-1RT inhibitors

Synthesis of 1-(Alkyl)-5-dimethylamino-6-phenethyluracils as Potent Nonnucleoside HIV-1 RT Inhibitors

The Design and Synthesis of N-1-Alkylated-5-Aminoaryalkylsubstituted-6-Methyluracils As Potential Non-Nucleoside Hiv-1 Rt Inhibitors

ChemInform Abstract: Structure‐Based Design, Synthesis and Biological Evaluation of New N‐Carboxyphenylpyrrole Derivatives as HIV Fusion Inhibitors Targeting gp41.

Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 7. Synthesis, Antiviral Activity, and 3D‐QSAR Investigations of Novel 6‐(1‐naphthoyl) HEPT Analogues.

Synthesis and Biological Evaluation of Novel 1-Aryl-5-iodo-6-benzyluracils As Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors

ChemInform Abstract: Improved Synthesis of 1‐[hexahydrocyclopenta [C]pyrrol‐2(1h)‐yl]‐3‐(4‐methylbenzenesulfonyl)urea.

Design, Synthesis and Biological Evaluations of Novel Oxindoles As HIV‐1 Non‐Nucleoside Reverse Transcriptase Inhibitors. Part 1.

Study On Hiv-1 Rt Inhibitor - I. Synthesis Of 1,3-Dibenzyl-6-(3,4-Epoxybutyl)Uracil

Synthesis and biological evaluation of novel 2-arylalkylthio-4-amino-6-benzyl pyrimidines as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.

ChemInform Abstract: Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 11. Structural Modulations of Diaryltriazines with Potent Anti‐hiv Activity.

Design, Synthesis, and Biological Evaluation of 1-[(2-benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils As Potent Hiv-1 Non-Nucleoside Reverse Transcriptase Inhibitors with an Improved Drug Resistance Profile

Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors: Part I. Synthesis and Structure-Activity Relationship of 1-Alkoxymethyl-5-alkyl-6-naphthylmethyl Uracils As HEPT Analogues.

Design, synthesis and anti-HIV evaluation of 5-alkyl- 6-(benzo[d][1,3]dioxol-5-alkyl)-2-mercaptopyrimidin-4(3H)-ones as potent HIV-1 NNRTIs

ChemInform Abstract: Synthesis and HIV‐1 Integrase Inhibition Activity of Some N‐Arylindoles.

ChemInform Abstract: N‐[2‐(1‐Cyclohexenyl)ethyl]‐N′‐[2‐(5‐bromopyridyl)]‐thiourea and N′‐[2‐(1‐Cyclohexenyl)ethyl]‐N′‐[2‐(5‐chloropyridyl)]‐thiourea As Potent Inhibitors of Multidrug‐Resistant Human Immunodeficiency Virus‐1.

Synthesis and Antifungal Activity of 2-Aryl-1,2,4-triazolo[1,5-a]pyridine Derivatives.

Synthesis and Biological Evaluation of (±)-Benzhydrol Derivatives As Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.